243 related articles for article (PubMed ID: 36080236)
1. Ajuforrestin A, an Abietane Diterpenoid from
Yan H; Jiang M; Yang F; Tang X; Lin M; Zhou C; Tan Y; Liu D
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080236
[TBL] [Abstract][Full Text] [Related]
2. A new abietane diterpenoid from Ajuga ovalifolia var. calantha induces human lung epithelial A549 cell apoptosis by inhibiting SHP2.
Liu DM; Cao ZX; Yan HL; Li W; Yang F; Zhao WJ; Diao QC; Tan YZ
Fitoterapia; 2020 Mar; 141():104484. PubMed ID: 31954180
[TBL] [Abstract][Full Text] [Related]
3. A new abietane diterpenoid glycoside from
Yang F; Chen HP; Shen XF; Chen HL; Chen Y; Wang LX; Zhang H; Zhao WJ; Zhang M; Tan YZ
Nat Prod Res; 2019 Oct; 33(19):2856-2859. PubMed ID: 30422013
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis Inhibitory Aromatic Abietane Diterpenoids from
Peng X; Tan Q; Wu L; Wu D; Xu J; Zhou H; Gu Q
J Nat Prod; 2022 Jul; 85(7):1808-1815. PubMed ID: 35796002
[TBL] [Abstract][Full Text] [Related]
5. Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways.
Fu NJ; Xi RY; Shi XK; Li RZ; Zhang ZH; Li LY; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2022 Apr; 441():115988. PubMed ID: 35307375
[TBL] [Abstract][Full Text] [Related]
6. Chemical Constituents of Ajuga Lupulina and their Anti-Ferroptosis Activity.
Teng X; Shi H; Cao L; Peng X; He L; Gu Q
Chem Biodivers; 2024 Apr; 21(4):e202400244. PubMed ID: 38426640
[TBL] [Abstract][Full Text] [Related]
7. Antifeedant, cytotoxic, and anti-inflammatory neo-clerodane diterpenoids in the peltate glandular trichomes and fresh leaves of Ajuga forrestii.
Wang Y; Liu YC; Li WY; Guo K; Liu Y; Li SH
Phytochemistry; 2021 Jun; 186():112731. PubMed ID: 33721797
[TBL] [Abstract][Full Text] [Related]
8. Five previously undescribed compounds from
Wang KJ; Bao TR; Yang YC; Wang DD; Wang AH; Gao XX; Yan T; Jia JM
Nat Prod Res; 2024; 38(3):503-511. PubMed ID: 36200694
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Vazhappilly CG; Saleh E; Ramadan W; Menon V; Al-Azawi AM; Tarazi H; Abdu-Allah H; El-Shorbagi AN; El-Awady R
Invest New Drugs; 2019 Apr; 37(2):252-261. PubMed ID: 29947013
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis and biological evaluation of aminopyrazines as highly potent, selective, and cellularly active allosteric SHP2 inhibitors.
Tang K; Zhao M; Wu YH; Wu Q; Wang S; Dong Y; Yu B; Song Y; Liu HM
Eur J Med Chem; 2022 Feb; 230():114106. PubMed ID: 35063735
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, activity and molecular dynamics studies of 1,3,4-thiadiazole derivatives as selective allosteric inhibitors of SHP2 for the treatment of cancer.
Liu WS; Zhao JF; Guo XJ; Lu SZ; Li W; Li WZ
Eur J Med Chem; 2023 Oct; 258():115585. PubMed ID: 37390510
[TBL] [Abstract][Full Text] [Related]
12. Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico study.
Ma CH; Zhao JF; Zhang XG; Ding CH; Hao HH; Ji YH; Li LP; Guo ZT; Liu WS
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127845. PubMed ID: 37935292
[TBL] [Abstract][Full Text] [Related]
13. Identification of the novel natural product inhibitors of SHP2 from the plant Toona sinensis: In vitro and in silico study.
Zhao JF; Wang RS; Lu SZ; Guo XJ; Chen Y; Li LH; Ding CH; Liu WS
Int J Biol Macromol; 2022 Nov; 221():679-690. PubMed ID: 36096249
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors.
Liu WS; Yang B; Wang RR; Li WY; Ma YC; Zhou L; Du S; Ma Y; Wang RL
Bioorg Chem; 2020 Jul; 100():103875. PubMed ID: 32380342
[TBL] [Abstract][Full Text] [Related]
15. Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation.
Liu WS; Jin WY; Zhou L; Lu XH; Li WY; Ma Y; Wang RL
J Comput Aided Mol Des; 2019 Aug; 33(8):759-774. PubMed ID: 31300938
[TBL] [Abstract][Full Text] [Related]
16. Structurally diverse abietane-type Diterpenoids from the aerial parts of Gaultheria leucocarpa var. yunnanensis.
Hu YJ; Lan Q; Su BJ; Chen ZF; Liang D
Phytochemistry; 2022 Sep; 201():113255. PubMed ID: 35636565
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors.
Kong J; Long YQ
RSC Med Chem; 2022 Mar; 13(3):246-257. PubMed ID: 35434626
[TBL] [Abstract][Full Text] [Related]
19. Discovery of allosteric SHP2 inhibitors through ensemble-based consensus molecular docking, endpoint and absolute binding free energy calculations.
Jama M; Ahmed M; Jutla A; Wiethan C; Kumar J; Moon TC; West F; Overduin M; Barakat KH
Comput Biol Med; 2023 Jan; 152():106442. PubMed ID: 36566625
[TBL] [Abstract][Full Text] [Related]
20. From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement.
Mostinski Y; Heynen GJJE; López-Alberca MP; Paul J; Miksche S; Radetzki S; Schaller D; Shanina E; Seyffarth C; Kolomeets Y; Ziebart N; de Schryver J; Oestreich S; Neuenschwander M; Roske Y; Heinemann U; Rademacher C; Volkamer A; von Kries JP; Birchmeier W; Nazaré M
J Med Chem; 2020 Dec; 63(23):14780-14804. PubMed ID: 33210922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
